After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, ORKA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Oruka Therapeutics Inc is $554.27M. A total of 89791.0 shares were traded on the day, compared to an average of 217.57K shares.
In the most recent transaction, Venrock Healthcare Capital Par bought 88,794 shares of ORKA for 11.44 per share on Feb 14 ’25. After the transaction, the 10% Owner now owns 4,148,428 company shares. In a previous transaction on Feb 13 ’25, Venrock Healthcare Capital Par bought 14,950 shares at 11.63 per share. ORKA shares that 10% Owner owns now total 4,059,634.
Among the insiders who bought shares, Venrock Healthcare Capital Par acquired of 8,971 shares on Feb 12 ’25 at a per-share price of $11.86. This resulted in the 10% Owner holding 4,044,684 shares of ORKA after the transaction. In another insider transaction, Venrock Healthcare Capital Par bought 9,593 shares at $10.95 per share on Feb 11 ’25. Company shares held by the 10% Owner now total 4,035,713.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ORKA has a high of $33.00 and a low of $5.49.
As of this writing, ORKA has an earnings estimate of -$0.55 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.48 per share and a lower estimate of -$0.6. The company reported an EPS of -$1.46 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORKA is Buy with a score of 4.80.
